Core domains of shared decision-making during psychiatric visits: scientific and preference-based discussions by Fukui, Sadaaki et al.
Core domains of shared decision-making during psychiatric 
visits: Scientific and preference-based discussions
Sadaaki Fukui, Ph.D [Director of Research],
The University of Kansas School of Social, Welfare Center for Mental Health Research and 
Innovation, 1545 Lilac Lane Lawrence, KS 66044, U.S. A TEL: (785)864-5874; FAX: 
(785)864-5277; fsadaaki@ku.edu
Marianne S. Matthias, Ph.D [Research Scientist], and
Roudebush VA Medical Center and Regenstrief Institute, Adjunct Assistant Professor, 
Department of Communication Studies, Indiana University-Purdue University Indianapolis, 1481 
W. 10th Street, Indianapolis, IN 46202, TEL: (317)988-4514; FAX: (317)988-5361; 
mmatthia@iupui.edu
Michelle P. Salyers, Ph.D. [Associate Professor]
Department of Psychology, Indiana University-Purdue University Indianapolis; Co-Director, ACT 
Center of Indiana, 402 N. Blackford Street, LD 124, Indianapolis, IN 46202, TEL: (317) 274-2904 
mpsalyer@iupui.edu
Abstract
Shared decision-making (SDM) is imperative to person-centered care, yet little is known about 
what aspects of SDM are targeted during psychiatric visits. This secondary data analysis (191 
psychiatric visits with 11 providers, coded with a validated SDM coding system) revealed two 
factors (scientific and preference-based discussions) underlying SDM communication. Preference-
based discussion occurred less. Both provider and consumer initiation of SDM elements and 
decision complexity were associated with greater discussions in both factors, but were more 
strongly associated with scientific discussion. Longer visit length correlated with only scientific 
discussion. Providers’ understanding of core domains could facilitate engaging consumers in 
SDM.
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Introduction
Shared decision-making (SDM) has become a central tenet of recovery and person-centered 
care delivery methods in mental health (Substance Abuse and Mental Health Services 
Administration, 2010). SDM is a collaborative communication process in which health 
decisions are made jointly by health care providers and consumers of health care services 
(Légaré, Turcotte, Robitaille et al. 2012). This practice is particularly desirable for 
preference-sensitive decisions (where there is more than one viable option for a given 
consumer that should be tailored to his/her preferences) requiring expertise from both 
parties: providers’ scientific- and clinically-based knowledge and consumers’ values and 
personal experiences with treatment options (Légaré and Witteman 2013; Veroff, Marr, 
Wennberg 2013). Accordingly, it is important for providers to 1) invite the consumer to 
participate in conversations around treatment decision-making; 2) provide evidence-based 
treatment options, ensuring consumer understanding; and 3)elicit and incorporate the 
consumer’s preferences in the decision-making (Légaré, Turcotte, Stacey et al. 2012; 
Makoul and Clayman 2006).
In order to establish optimal treatment plans through SDM, one of the participants (either the 
provider or the consumer) needs to initiate a discussion of options (Makoul and Clayman 
2006; Tai-Seale, Foo, Stults 2013). Although people with a mental illness have strong 
desires for involvement in decision-making (Hamann et al. 2011; Puschner et al. 2010), 
research has not captured interactions in which consumers regularly initiate conversation in 
treatment decision making (Fukui et al. 2013). This apparent lack of consumer engagement 
implies an important role for providers to explicitly welcome the consumer as a partner in 
the decision-making process. This notion is consistent with recommendations by Braddock 
et al. (1997, 1999, 2008) that a fundamental component of SDM should be explicit 
discussions about either the consumer’s role in decision-making or exploration of consumer 
preferences along with the clinical issue or nature of the decision. Even for the most basic 
decisions (e.g., changing the timing of a medication), there should be some discussion of the 
consumer’s role in decision-making (Elwyn et al. 2005).
Another important component of SDM is information sharing and seeking (Puschner et al. 
2010). Much information exchange is rooted in scientific evidence and a provider’s clinical 
experience. This type of information includes identification of clinical issues, available 
treatment options, pros and cons of treatments under consideration, and uncertainties 
associated with treatment options (Braddock et al. 1997, 1999, 2008). The information 
should be up to date, relevant to consumers’ situation, and shared in an understandable 
manner. Prior studies have shown that complex decisions, depending on the level of risk and 
uncertainty, generally require more information sharing and increased need for SDM 
(Bhugra, Easter, Mallaris, Gupta 2011; Braddock et al. 1999; Fukui et al. 2013; Whitney, 
McGuire, McCullough 2004).
Finally, discussion of consumers’ preferences and values should be central in SDM (Baker 
et al. 2013; Braddock 2013; Institute of Medicine 2006; Substance Abuse and Mental Health 
Services Administration 2010). Although treatment options should be rooted in scientific 
evidence and clinical experience, options are often accompanied by uncertainties. In some 
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cases, these uncertainties are related to a treatment’s effectiveness; in other cases, 
uncertainties may be related to consumers’ concerns about how the expected outcomes and 
side effects of a treatment in question fit into their own lifestyle, preferences, and values. 
Thus, incorporating the consumer’s preferences for alternative options is important.
SDM tools identifying the extent to which essential elements of SDM have taken place 
during a psychiatric visit are important for identifying and improving best practices. Several 
measures have been developed to assess SDM practice, through both the consumer’s and the 
provider’s perceived experiences, as well as observations by third parties (Elwyn et al. 2001; 
Scholl et al. 2011; Simon, Loh, Härter 2007). However, self-report measures may not 
adequately capture the interactive decision-making process and may be more prone to bias 
than observation (Fukui et al. 2013).
We recently adapted a coding system to measure elements of SDM during a psychiatric visit 
using trained raters (Salyers et al. 2012) based on an existing measure – the Informed 
Decision Making Scale (Braddock et al. 2008). The SDM coding system rates the degree to 
which observable communication appears (0=absent; 1=partial; 2=complete) for nine 
elements of SDM: 1) consumer’s role in decision-making; 2) consumer’s goal/context of 
decision; 3) clinical issue or nature of the decision; 4) alternative options; 5) pros and cons; 
6) uncertainties associated with the decision; 7) assessing consumer’s understanding; 8) 
assessing consumer’s desire for others’ input; and 9) exploration of consumer preference. 
These elements evaluate the important aspects of SDM – empowerment (Element 1), 
information sharing (Elements 2,3,4,5), and preference clarification (Elements 6,7,8,9) with 
face and content validity (Leader et al. 2012). In addition, decisions are classified as basic, 
intermediate, or complex. Decisions with high medical consensus that pose little risk to the 
consumer are categorized as basic decisions (e.g., timing of medication dose). Decisions are 
considered complex when they have uncertain outcomes or high controversy in the 
literature, and could have extensive impact on a consumer (e.g., starting a new prescription 
of clozapine). Intermediate decisions fall in between in terms of medical consensus and 
impact on a consumer.
The nine elements of the coding system have been shown to effectively characterize the 
SDM process during psychiatric visits (Salyers et al. 2012). We also identified that decision 
complexity and consumer initiation were significant predictors of higher occurrence of SDM 
(Fukui et al. 2013). However, we have limited understanding of how the nine SDM elements 
are related to one another beyond the theoretical framework and how predictors are related 
to different aspects of SDM. In the current study, we sought to better understand the SDM 
process by examining underlying structures of the coding system and what predictors are 
related to those factors. A better understanding of these characteristics could enhance 
designing targeted interventions to improve SDM in mental health care.
Method
Datasets used in this study
We conducted secondary data analysis using four independently collected datasets of audio-
recorded psychiatric visits. These included 1) an observational study of 40 psychiatric visits 
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(4 providers, with 10 consumers each) (Salyers et al. 2009); 2) a baseline assessment (prior 
to intervention) in a randomized control trial of CommonGround, an intervention to improve 
SDM (3 providers and 98 consumers) (Deegan, Rapp, Holter, Riefer 2008); 3) an 
observational study of 48 psychiatric visits with one provider; and 4) an observational study 
of 76 psychiatric visits with 3 providers. The first three studies took place in community 
mental health centers, and the fourth was conducted in a VA Medical Center outpatient 
mental health clinic. The audio-recordings were transcribed, checked for accuracy, and 
coded by trained raters using the SDM coding system (Salyers et al. 2012). Sixteen audio-
recordings were dropped from the sample due to technical difficulties. Fifty five (22%) of 
the remaining 246 transcripts did not contain any clinical decisions (i.e., discussion with an 
explicit course of action); rather, these were predominately check-in visits concerning the 
consumer’s progress. This left 191 transcripts in the analyses reported here. All studies were 
approved by the local Institutional Review Boards.
The mean age of consumers was 46.5 (SD = 11.4); 119 (62%) were male; and 74 (39%) had 
a schizophrenia diagnosis. One hundred twelve (59%) identified themselves as white, 65 
(34%) as African American, 5(3%) as Hispanic, and 4% as “other” (including native 
American and Asian). Six providers were psychiatrists and five were nurse practitioners. 
Seven of the providers were female. Other provider characteristics such as age, race, and 
length of practice experience were not available in the original datasets. The mean length of 
the recorded visit was 18.2 minutes (SD=7.4); 77 (40%) had “basic decision”; 110 (58%) 
had an “intermediate decision”; and 4 (2%) had a “complex decision.”
Data Analyses
An exploratory factor analysis (a principal axis factoring method with promax rotation) was 
conducted to identify the underlying structures of the SDM coding system. Since the SDM 
coding system uses an ordinal scale (0=absent; 1=partial; 2=complete), a polychoric 
correlation matrix was used for the analysis. The number of factors extracted was 
determined based on scree tests, Kaiser’s criterion (i.e., eigenvalues greater than one), and 
interpretability. Items were considered for elimination if they had low factor loadings for all 
factors (i.e., < 0.30), cross-loadings, or were too highly correlated with other items (i.e., > 
0.80). In addition, bivariate relationships were examined to see if there were significant 
relationships between SDM and other variables available in the datasets (i.e., who initiated 
the elements in SDM, consumer demographics [age, gender, race], diagnosis [schizophrenia 
vs. other], length of visit, decision complexity) by accounting for the effect of providers 
(i.e., consumers nested within providers). SAS ver. 9.2 was used for the analyses.
Results
The analysis resulted in a two-factor solution best describing the underlying structures of the 
SDM coding system after exploring potential one- and three-factor models. The rotated 
factor loadings are presented for interpretability [Browne 2001] (See Table 1). Kaiser’s 
Measure of Sampling Adequacy was 0.7. We identified the first factor as “scientific 
discussion” – sharing and seeking scientific-based treatment options and assuring 
consumer’s goal/context and understanding (i.e., nature of the decision, pros and cons, 
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uncertainties, goals/context, understanding). The second factor was identified as 
“preference-based discussion” – a discussion of consumer’s role in decision-making, 
consumer preferences, and alternative treatment options. The two factors were correlated at .
27. The element “assessing consumer’s desire for others’ input” was dropped from the factor 
analysis because it caused an estimation problem due to a rare event (i.e., 91% did not 
discuss the element at all). As shown in Table 1, the mean difference between the two 
domains showed that scientific discussion occurred more completely than preference-based 
discussion (p<.01).
In terms of correlates of SDM (See Table 2), initiation scores (indications of who initiated 
each element in the SDM coding system) were strongly correlated with scientific discussion 
but were more weakly correlated with preference-based discussion (for both consumer and 
provider initiation of discussion). In addition, provider initiation scores were more strongly 
correlated with both discussions compared to consumer initiation scores. Finally, more 
complex decisions (basic vs. intermediate or complex) and longer length of visit were 
associated with more scientific discussion (p<.001), while preference-based discussion was 
only associated with complex decisions (p<.01), but not length of visit. Given the prior 
finding that SDM was not related to length of visit after controlling for decision complexity 
using the subsets of the current data (Salyers et al. 2012), we also evaluated the partial 
correlation between length of visit and scientific discussion. After controlling for the 
decision complexity, length of visit was still significantly correlated with scientific 
discussion (r= 0.18 p<.05).
Discussion
This is the first study we are aware of that examined factor structures underlying observed 
SDM in mental health. Results revealed two factors – scientific discussion and preference-
based discussion, which were fairly independent of each other, and which had different 
correlates. These two core components of SDM are consistent with the conceptual 
understanding of good quality SDM deliberation that relevant options based on scientific 
evidence and consumer preferences/values should be discussed (Leader et al. 2012). In 
addition, based on a systematic review by Makoul and Clayman (2006), these two 
components were the most prevalent in definitions of SDM.
Scientific discussion included the clinical issue or nature of decision, pros and cons of 
different treatment options, uncertainties associated with the decision, the consumer’s goal/
context of decision, and assessment of the consumer’s understanding. This is consistent with 
Makoul and Clayman’s systematic review (2006), which identified essential and ideal 
elements of SDM. These authors noted that consumers and providers must first identify the 
nature of the decision that needs to be addressed, along with pros and cons and uncertainties 
associated with the decision.
In addition, two other elements loaded onto this factor. Contrary to our expectations, 
discussion of consumer’s goal/context of decision was associated with this factor rather than 
the second factor focusing more on preferences. First, given the ideal situation that 
information sharing should occur when it is most relevant to consumers’ goal/context, it 
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may be that the consumer’s goal/context was more likely to be discussed while information 
is shared rather than when preferences are being evaluated. Second, like other chronic 
medical conditions (Watt, 2000), psychiatric disabilities involve long-term illness 
management and much uncertainty associated with the treatment decisions that impact 
consumers’ lives. Further, psychiatric rehabilitation has placed a great value on consumer 
goal setting, achievement, and treatment to enhance consumer goals (Anthony and Liberman 
1994; Anthony 1982; Corrigan et al. 2008). Providers should be oriented to exchange 
scientific information according to the consumer’s goal and context. With consumer-tailored 
information, based upon consumer goals/contexts, consumer preference then can be 
evaluated. However, both this element and assessment of consumer’s understanding loaded 
weakly on the scientific discussion factor. This suggests that there could be another potential 
factor explaining the two elements. For example, a potential third factor could involve 
creating a feedback loop between the two components – tailoring information and 
personalizing communication with consumer evaluations and preferences, which may 
distinguish SDM from the notion of simple information exchange or informed consent. 
However, the current SDM coding system (and/or sample we used) did not appear to reflect 
an independent third factor in our analyses.
The second factor, preference-based discussion, included discussions of consumers’ desired 
role in making the decision, exploring preferences, and suggesting alternatives. Other 
studies show consumers desire a choice about the use of medications to their recovery 
(Curtis et al. 2010). Regardless of the scientific evidence, some medications could also be an 
unwanted reminder of illness and have attached social stigma for some consumers (Deegan 
and Drake 2006). Some consumers may prefer developing their own coping strategies, 
rather than taking prescribed medications or using a combination of both. These non-
medication alternatives may include “self-monitoring,” “getting in a routine,” “increased 
activity,” “prayer,” and “seeking out support from others” (Young and Ensing 1999). These 
strategies are also reflected in work by Deegan (2005, 2007), who introduced the notions of 
“personal medicine” (self-initiated, non-pharmaceutical self-care activities) and “power 
statement” (reflecting the person’s overarching goals for using psychiatric medication), 
specifically in psychiatric visits. Work such as this illustrates that there can sometimes be a 
wide gap between provider judgment and consumer preferences (e.g., providers may value 
clinical outcomes while consumers may value long-term side effect and quality of life) 
(Mühlbacher and Juhnke 2013), making SDM even more important. Notably in our samples, 
preference-based discussion occurred less completely than scientific discussion.
While we have identified two core SDM domains, in somatic medicine, the OPTION scale – 
another reliable scale to code observed SDM during medical visits (Elwyn et al. 2003; 
Elwyn et al. 2005) – was found to have a single factor structure based on a factor analysis 
(Gagnon et al. 2010). The OPTION scale and SDM coding system contain many elements in 
common (Weiss and Peters 2008) and are conceptually similar (Elwyn et al. 2001). 
However, given the lack of correlation between overall scores on the two scales (Weiss and 
Peters 2008), they may be tapping into different domains at the construct level. Weiss and 
Peters (2008) discussed that some elements of SDM – with more specific and clearer 
concept – may be easier to capture than others. It is possible that the essential elements 
could be differently captured and vary with context (Leader et al. 2012). Our findings may 
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reflect characteristics of SDM in mental health, which could theoretically be different than 
other medical conditions.
In predictive analyses, initiation of elements by both providers and consumers was weakly 
correlated to preference-based discussion compared to scientific discussion. It also appears 
that, for both scientific and preference-based discussions, provider initiation may be more 
likely to lead to more robust discussions than when these discussions are initiated by 
consumers. These findings imply that, given the limited consultation time, scientific 
discussion tends to be prioritized during a psychiatric visit, particularly when the SDM 
elements are initiated by providers. This provider-initiated conversation could also result in 
or could be result of the lower consumer initiation (see Table 2).
Further, as decision complexity increased, both scientific discussion and preference-based 
discussions occurred more completely. Complex decisions involve greater uncertainty, 
which should necessitate sufficient exploration of the evidence for the treatment in question. 
Complex decisions with high uncertainty should also elicit more discussion related to 
consumers’ preferences.
Finally, even after controlling for the decision complexity, longer length of visit was 
significantly associated with greater scientific discussion. In our other analyses (Fukui et al. 
2013; Salyers et al. 2012) using the subsets of the current data found that controlling for 
complexity, SDM was not related to length of visit. However, those studies did not examine 
the different factors of SDM. Information sharing may require more time despite the level of 
complexity. On the other hand, preference-based discussions were not related to length of 
visit. If these findings replicate, this may alleviate concerns providers have about adding to 
the length of the visit by spending more time on preference-based discussions.
Given the available data (combined samples from community mental health center and VA) 
and exploratory nature of the study, the findings may have limited generalizability and 
future examinations will be needed. We also lack information on other potentially important 
variables, such as length of relationship with the provider, education level, etc. Lastly, the 
item “assessing consumer’s desire for others’ input” was dropped from the analysis, but the 
functioning of the item in this study may reflect the sample – 91% did not discuss the 
element. Given that the role of formal and informal support with the long-term commitment 
could be important in SDM (Watt 2000; Woltmann and Whitley 2010), this item should not 
be devalued based solely on the results of this study.
In spite of the limitations, this study’s findings provide a framework for understanding the 
underlying characteristics of SDM in mental health. Information sharing includes 
discussions on the scientific evidence of treatment options according to the potential impact 
on the consumer’s life and consumer understanding. Discussion/evaluation of consumer 
preferences on the treatment options is also a core component of SDM. SDM is deeply 
rooted in context, both in terms of treatment history and the larger context of the consumer-
provider relationship (Matthias, Salyers, Frankel 2013). As a result, different elements of 
SDM may be present to varying degrees, depending on the situation. Enhancing providers’ 
understanding of the core factors of evidence-based and preference-based discussion 
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underscore the need for providers to engage consumers with mental illness in SDM when 
making treatment decisions.
Conclusions
The development of psychiatric medication was a breakthrough in mental health history, and 
improved adherence to prescribed medication has been a major focus of practice and 
research. However, the recovery movement has highlighted that medications should not 
control or determine people’s lives. The incorporation of consumers’ voices and preferences 
is an important characteristic of SDM and is highly consistent with recovery-oriented mental 
health treatment (Baker et al. 2013). Our study has identified two important domains of 
SDM— scientific and preference-based discussion—that may guide providers when 
engaging consumers in decision-making in relation to medications.
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Table 1
Result of factor analysis and mean difference between factors
Factor1 Factor2 Mean Difference
Factor 1: Scientific discussion t (190)=2.68, p<.01
Discussion of the pros and cons 0.868 0.020
Discussion of the clinical issue or nature of the decision 0.789 −0.153
Discussion of uncertainties associated with the decision 0.727 0.143 M=1.23 (SD= .44)
Discussion of consumer's goal/context of decision 0.380 0.032
Assessment of the consumer's understanding 0.307 0.154
Factor 2: Preference-based discussion
Discussion of the consumer's role in decision making −0.168 0.690
Discussion of the alternatives 0.250 0.575 M= 1.13 (SD= .47)
Exploration of consumer preference 0.263 0.369
Note: Mean score range (Factor 1 and Factor 2) is 0–2
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Table 2
Correlations and t-tests between SDM and other variables with standard errors corrected for the consumer-
provider nested effect
Scientific discussion Preference-based discussion
Provider Initiation Score (M = 4.99 [SD=2.07]) r = .61*** r = .36***
Consumer Initiation Score (M = 1.92 [SD=1.44]) r = .37*** r = .24***
Consumer Age r = −.02, p =.81 r = − .02, p = .78
Length of Visit r = .29*** r = .01, p = .86
Consumer Gender (male = 1) t (179) = 1.34, p = .18 t (179) = .40, p = .69
Consumer Race (white = 1) t (179) = − .59, p = .55 t (179) = .61, P = .54
Consumer Diagnosis (schizophrenia = 1) t (179) = − .61, p = .54 t (179) = 1.52, p = .13
Type of Decision (intermediate/complex = 1) t (179) = 7.82*** t (179) = 3.20**
*
p<.05,
**
p<.01,
***
p<.001
Adm Policy Ment Health. Author manuscript; available in PMC 2015 January 08.
